Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. Finn RS, Qin S, Ikeda M, Galle PR, et al. N Engl J Med 2020;382:1894-1905.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Finn RS, Qin S, Ikeda M, Galle PR, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med 2020;382:1894-1905.
PMID: 32402160